Detalles de la búsqueda
1.
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
Biol Blood Marrow Transplant
; 19(4): 552-61, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23253557
2.
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
Biol Blood Marrow Transplant
; 18(2): 324-9, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22079471
3.
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.
Pediatr Transplant
; 13(4): 464-74, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18785912
4.
An Innovative Hybrid Clinical Model: Useful for a Clinical Makeup in Prelicensure Nursing Practicums.
Nurse Educ
; 48(5): E152, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36877994
5.
A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.
Biol Blood Marrow Transplant
; 12(11): 1188-97, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17085312
Resultados
1 -
5
de 5
1
Próxima >
>>